Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190506043492N4
IRCT20190506043492N4
Completed
Phase 3

Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unit

Ahvaz University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute respiratory distress syndrome.Acute respiratory distress syndrome

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute respiratory distress syndrome.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients 18 to 60 years
  • •Under mechanical ventilation for more than 48 hours
  • •Respiratory index PAO2 / FIO2 \=200 mmhg
  • •Bilateral pulmonary infiltration in the chest x\-ray
  • •Lack of heart disease and previous lung disease
  • •Positive end expiratory pressure or PEEP\= ventilator 5 cmh2
  • •No history of intracerebral hemorrhage in the past 12 months
  • •No history of heparin\-induced thrombocytopenia

Exclusion Criteria

  • •Dissatisfaction to continue working on the study
  • •Hypersensitivity to heparin
  • •Uncontrolled bleeding or bleeding disorders
  • •PTT and INR impaired
  • •Patients receiving therapeutic doses of heparin, anaxaparin and warfarin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3
IRCT20211010052718N2Mazandaran University of Medical Sciences74
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart disease
IRCT201202199080N1Hamadan university of medical sciences500
Completed
Phase 2
Inhaled heparin in pneumoniaVENTILATOR ASSOCIATED PNEUMONIA(VAP).Ventilator associated pneumoniaJ95.851
IRCT20140310016917N8Vice chancellor for research of Guilan University of Medical Sciences42
Recruiting
Phase 3
Comparison of inhaled heparin/N-acetylcysteine, N-acetylcystein alone, and placepo for the treatment of COVID-19 patientsCOVID-19.Coronavirus infection, unspecifiedB34.2
IRCT20201210049672N1Vice-Chancellery for Research Hormozgan University of Medical Sciences25
Completed
Not Applicable
Feasibility and safety of inhaled heparin in intubated and mechanically ventilated patients: a randomised controlled trial comparing three doses of inhaled unfractionated hepari
ISRCTN28587216Academic Medical Center (AMC) (The Netherlands)24